Rossi F. Towards a compulsory license for Dolutegravir in Colombia. Salud UIS [Internet]. 2023 Oct. 25 [cited 2024 May 18];55. Available from: https://revistas.uis.edu.co/index.php/revistasaluduis/article/view/14739